207 related articles for article (PubMed ID: 18330899)
1. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
Li Y; Friedmann DR; Mhatre AN; Lalwani AK
Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
[TBL] [Abstract][Full Text] [Related]
2. In vitro expression and characterization of MYH9 mutant alleles linked to hereditary hearing loss.
Wei CC; Lalwani AK; Mhatre AN
Otolaryngol Head Neck Surg; 2010 May; 142(5):699-703. PubMed ID: 20416459
[TBL] [Abstract][Full Text] [Related]
3. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
4. Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.
Takubo T; Wakui S; Daigo K; Kurokata K; Ohashi T; Katayama K; Hino M
Eur J Histochem; 2003; 47(4):345-52. PubMed ID: 14706930
[TBL] [Abstract][Full Text] [Related]
5. Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources.
Parker LL; Gao J; Zuo J
Brain Res; 2006 May; 1091(1):235-42. PubMed ID: 16630581
[TBL] [Abstract][Full Text] [Related]
6. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.
Kohlstedt K; Kellner R; Busse R; Fleming I
Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of MYH9 expression by short hairpin RNA expression vector in human umbilical vein endothelial cells (HUVEC)].
Huang YL; Kou JP; Song JX; Yu BY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1160-3. PubMed ID: 19068200
[TBL] [Abstract][Full Text] [Related]
8. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
Morimura S; Suzuki K; Takahashi K
Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
[TBL] [Abstract][Full Text] [Related]
10. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
11. MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.
Pecci A; Ma X; Savoia A; Adelstein RS
Gene; 2018 Jul; 664():152-167. PubMed ID: 29679756
[TBL] [Abstract][Full Text] [Related]
12. Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain.
Obungu VH; Lee Burns A; Agarwal SK; Chandrasekharapa SC; Adelstein RS; Marx SJ
Oncogene; 2003 Sep; 22(41):6347-58. PubMed ID: 14508515
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice.
Matsushita T; Hayashi H; Kunishima S; Hayashi M; Ikejiri M; Takeshita K; Yuzawa Y; Adachi T; Hirashima K; Sone M; Yamamoto K; Takagi A; Katsumi A; Kawai K; Nezu T; Takahashi M; Nakashima T; Naoe T; Kojima T; Saito H
Biochem Biophys Res Commun; 2004 Dec; 325(4):1163-71. PubMed ID: 15555549
[TBL] [Abstract][Full Text] [Related]
14. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
[TBL] [Abstract][Full Text] [Related]
15. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells.
Pecci A; Bozzi V; Panza E; Barozzi S; Gruppi C; Seri M; Balduini CL
Thromb Haemost; 2011 Oct; 106(4):693-704. PubMed ID: 21833445
[TBL] [Abstract][Full Text] [Related]
16. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
17. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA.
Huang Y; Arora P; McCulloch CA; Vogel WF
J Cell Sci; 2009 May; 122(Pt 10):1637-46. PubMed ID: 19401332
[TBL] [Abstract][Full Text] [Related]
18. MYH9-related platelet disorders.
Althaus K; Greinacher A
Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
[TBL] [Abstract][Full Text] [Related]
19. Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear.
Mhatre AN; Li J; Kim Y; Coling DE; Lalwani AK
J Neurosci Res; 2004 May; 76(3):296-305. PubMed ID: 15079858
[TBL] [Abstract][Full Text] [Related]
20. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
